Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutic products for the acute treatment of migraines. Their lead product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, currently in SUMMIT Phase 3 efficacy trials. Satsuma Pharmaceuticals aims to provide a self-administered solution for migraine treatment using a proprietary pre-filled, single-use, and nasal delivery device. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutic products for the acute treatment of migraines. Their lead product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, currently in SUMMIT Phase 3 efficacy trials. Satsuma Pharmaceuticals aims to provide a self-administered solution for migraine treatment using a proprietary pre-filled, single-use, and nasal delivery device. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
satsumarx.com
400 Oyster Point Boulevard, South San Francisco, 94080, US
Details
Year founded
2016
Revenue
0-500K
Employees
11-50
Number of locations
2
NAICS
325412
SIC
2834
Products & Services
Outlines the company's specialized services and operational strengths.
- Biopharmaceuticals
- Dihydroergotamine
- Pharmaceuticals
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- Powder technology for DHE nasal powder
- Nasal delivery device for DHE product
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
TRUE
Our production algorithm is showing that satsuma pharmaceuticals is ramping up production.
Target industries
Employees working in Satsuma Pharmaceuticals, Inc.
News
Satsuma Pharmaceuticals and SNBL Announce Five Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society's 66th Annual Scientific Meeting
Satsuma Pharmaceuticals and SNBL Announce Five Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society's 66th Annual Scientific Meeting
PRNewswire/ -- Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company currently seeking regulatory approval from the U.S. Food and Drug...
Locations (2)
Satsuma Pharmaceuticals, Inc.
400 Oyster Point Boulevard, South San Francisco, 94080, US
Satsuma Pharmaceuticals, Inc.
4819 Emperor Blvd Suite 340, Durham, NC 27703, United States
People Also Searched For
Frequently Asked Questions
What services & capabilities does Satsuma Pharmaceuticals, Inc. offer?
Satsuma Pharmaceuticals, Inc. offers a range of services and capabilities, including Biopharmaceuticals.
What kind of equipment does Satsuma Pharmaceuticals, Inc. use?
Satsuma Pharmaceuticals, Inc. uses a variety of equipment, including Powder technology for DHE nasal powder.
What are the target industries of Satsuma Pharmaceuticals, Inc.?
Satsuma Pharmaceuticals, Inc. serves several industries, including the medical industry.
How many locations does Satsuma Pharmaceuticals, Inc. operate?
Satsuma Pharmaceuticals, Inc. operates from 2 locations.
Where are the headquarters of Satsuma Pharmaceuticals, Inc.?
The headquarters of Satsuma Pharmaceuticals, Inc. are located in 400 oyster point boulevard south san francisco, south san francisco, california 94080, united states.
What is the NAICS code for Satsuma Pharmaceuticals, Inc.?
The NAICS code for Satsuma Pharmaceuticals, Inc. is 325412.
How many employees does Satsuma Pharmaceuticals, Inc. have?
Satsuma Pharmaceuticals, Inc. has 25 employees.
What is the official website of Satsuma Pharmaceuticals, Inc.?
The official website of Satsuma Pharmaceuticals, Inc. is https://www.satsumarx.com.
When was Satsuma Pharmaceuticals, Inc. founded?
Satsuma Pharmaceuticals, Inc. was founded in 2016.